The Food and Drug Administration (FDA) has approved a domestically-developed and produced antibody reagent for the COVID-19 coronavirus disease, the first of its kind licensed in Taiwan, an FDA official said Friday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taipower activates 5 standby units to cope with low power reserve
09/17/2025 11:13 PM - Business
Taiwan Expo opens in the Philippines; US$50m in business deals expected
09/17/2025 10:58 PM - Culture
'Taiwan Travelogue' translator nominated for 2 translation awards in U.S.
09/17/2025 09:53 PM - Society
22% of Taiwanese teens report suicidal thoughts: Survey
09/17/2025 08:33 PM - Politics
China's military parade could hurt optics: Military spokesman
09/17/2025 08:19 PM